ebook Munafa Stock Market Course + Intraday & FNO calls  

       

SPXV announcements S&p 500 Ex-health Care Proshares announcements and dividends declared AMEX

S&p 500 Ex-health Care Proshares Complete list of announcements declared & dividend announcements by S&p 500 Ex-health Care Proshares SPXV

S&p 500 Ex-health Care Proshares SPXV listed on AMEX and deals in

Announcements and dividends declared by S&p 500 Ex-health Care Proshares SPXV

Why the RBI is weighing a rare 2013-crisis playbook to arrest rupee slide to record lows?
The rupee’s slide to fresh record lows and oil above 0 has prompted the RBI to revisit crisis-era tools from 2013, including a special NRI dollar deposit window and possible tax relief for foreign bond investors. With reserves dipping and outflows risin
Announcement as on 04 May 2026

West Bengal election results put these 43 stocks under spotlight. Will BJP's win be a trigger?
Early West Bengal election trends putting BJP ahead of TMC have pushed stocks like Bandhan Bank, CESC, and Berger Paints into focus. Investors are watching potential policy shifts, though analysts say the impact will be short-lived, with broader cues such
Announcement as on 04 May 2026

Nestlé India flags Iran war risks, holds prices amid cost pressures
Nestle India faces economic challenges including the Iran war, inflation, and a weak monsoon prediction. The company is increasing advertising, technology, and capital expenditure to manage these uncertainties. Despite these factors, Nestle India reported
Announcement as on 04 May 2026

Godrej Properties posts quarterly profit rise on housing demand
Indian real estate developer Godrej Properties reported ?a 70% rise in ?fourth-quarter profit on Monday as demand ?for residential apartments stayed high.
Announcement as on 04 May 2026

Mirum Pharma's Phase 2b Study Of Volixibat For Sclerosing Cholangitis Meets End Point, Shares Gain
(RTTNews) - Mirum Pharmaceuticals, Inc. (MIRM), Monday said that its VISTAS Phase 2b study evaluating Volixibat met primary endpoint in patients with primary sclerosing cholangitis or PSC. The company said the result support the potential for Volixibat as
Announcement as on 04 May 2026

Announcements by S&p 500 Ex-health Care Proshares first page | Next page | Prev page |

SPXV S&p 500 Ex-health Care Proshares current price & indicator signals

Moving Averages for S&p 500 Ex-health Care Proshares

  • 5Day Average: 79.53
  • 12Day Average: 78.84
  • 20Day Average: 77.84
  • 50Day Average: 74.84
  • 100Day Average: 74.95
  • 150Day Average: 74.54
  • 200Day Average: 73.6

SPXV Indicators & signals

Indicator MACD (12,26,9)

78.68, 77.16, 1.46
Indicator MACD is in positive zone

Indicator ADX (14)

46.67, 61.97, 22.54
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 56
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of SPXV S&p 500 Ex-health Care Proshares are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
06 Wed May 2026 79.54 81.25 to 81.25 0% 0 times
05 Tue May 2026 79.54 79.95 to 79.95 0% 0 times
04 Mon May 2026 79.54 79.54 to 79.72 -0.15% 0.32 times
01 Fri May 2026 79.66 79.66 to 79.96 0.38% 2.32 times
30 Thu Apr 2026 79.36 78.70 to 79.36 1.02% 0.9 times
29 Wed Apr 2026 78.56 78.30 to 78.56 -0.04% 0.21 times
28 Tue Apr 2026 78.59 78.59 to 78.59 -0.43% 0.09 times
27 Mon Apr 2026 78.93 78.75 to 78.97 0.46% 4.96 times
24 Fri Apr 2026 78.57 78.57 to 78.57 0.64% 0.17 times
23 Thu Apr 2026 78.07 77.90 to 78.34 -0.17% 0.77 times
22 Wed Apr 2026 78.20 78.20 to 78.27 0.83% 0.26 times
21 Tue Apr 2026 77.56 77.56 to 77.60 -0.56% 0.32 times

Videos related to: SPXV announcements S&p 500 Ex-health Care Proshares announcements and dividends declared AMEX

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

SPXV announcements S&p 500 Ex-health Care Proshares announcements and dividends declared AMEX

 

Back to top